business
InspireMD Q2 Revenue Flat; International Sales Rise 21% As Company Advances CGuard U.S. Relaunch
InspireMD, Inc. (NSPR), a medical device company developing the CGuard Prime carotid stent system for stroke prevention, reported financial results for the second quarter ended June 30, 2026, alongside updates on its U.
Read full article on Rttnews